- $8.14bn
- $8.16bn
- $1.81bn
US RESEARCH ROUNDUP-3M, C4 Therapeutics, PepsiCo
US RESEARCH ROUNDUP-Affiliated Managers Group, Goldman Sachs, Vaxcyte
Kinsale Capital Group Inc reports results for the quarter ended June 30 - Earnings Summary
Kinsale Capital Q2 gross written premiums fall 5% on commercial property competition
Kinsale Capital Group Inc expected to post earnings of $5.10 a share - Earnings Preview
U.S. RESEARCH ROUNDUP- Anterix, Fidus Investment, Nextpower
U.S. RESEARCH ROUNDUP- Applied Materials, Axsome Therapeutics, Onsemi
U.S. RESEARCH ROUNDUP-East West Bancorp, Reliance, S&P Global
U.S. RESEARCH ROUNDUP-East West Bancorp, Reliance, S&P Global
Brief: Kinsale Capital Q1 EPS USD 4.88
U.S. RESEARCH ROUNDUP- Carnival, Five Below, McKesson
BMO cuts Kinsale Capital PT on softer underwriting, investment income
U.S. STOCKS ON THE MOVE-Ormat Technologies, Southwest Airlines, Jack Henry
U.S. RESEARCH ROUNDUP-Brixmor Property, Mohawk Industries, UDR
U.S. STOCKS ON THE MOVE-Ormat Technologies, Accenture, Kinsale Capital
U.S. STOCKS ON THE MOVE-Albemarle, Fiserv, ConocoPhillips
Truist cuts Kinsale Capital PT on weaker premium growth
U.S. RESEARCH ROUNDUP-Brixmor Property, Mohawk Industries, UDR
Kinsale Capital Q4 net income rises 27% on higher premiums